Form 4 for CL Colgate-Palmolive
Accepted 2023-09-15 00:00:00 ET · period of report 2023-09-13 · accession 0001225208-23-008957 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-15 | 2023-09-13 | CL | Massey Sally | CHRO | A - Grant | $0.00 | +3,461 | 12.1K | +40% | $0 |
| D | 2023-09-15 | 2023-09-13 | CL | Massey Sally | CHRO | A - Grant | $0.00 | +25.4K | 25.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-13 | A | A | 3,461 | $0.00 | 12,121 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-09-13 | A | A | 25,387 | $0.00 | 25,387 | D | $72.83 · — to 2031-09-13 | 25,387 Common Stock | (F3) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 13, 2023 grant date. |